Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0O5QL
|
||||
Former ID |
DIB008921
|
||||
Drug Name |
HT-1067
|
||||
Synonyms |
MOA-B inhibitor (memory impairement) Helicon; MOA-B inhibitor (cognitive disorder/Parkinson's Disease) Helicon
|
||||
Indication | Parkinson's disease [ICD9: 332; ICD10:G20] | Discontinued in Phase 1 | [549231] | ||
Company |
Dart neuroscience
|
||||
Target and Pathway | |||||
Target(s) | Amine oxidase [flavin-containing] B | Target Info | Inhibitor | [549232] | |
KEGG Pathway | Glycine, serine and threonine metabolism | ||||
Arginine and proline metabolism | |||||
Histidine metabolism | |||||
Tyrosine metabolism | |||||
Phenylalanine metabolism | |||||
Tryptophan metabolism | |||||
Drug metabolism - cytochrome P450 | |||||
Metabolic pathways | |||||
Serotonergic synapse | |||||
Dopaminergic synapse | |||||
Cocaine addiction | |||||
Amphetamine addiction | |||||
Alcoholism | |||||
Pathway Interaction Database | Alpha-synuclein signaling | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.